1 / 1
PT-141, also known as Bremelanotide, is a synthetic peptide active pharmaceutical ingredient (API) classified as a melanocortin receptor agonist. Unlike compounds that act through peripheral vascular mechanisms, PT-141 primarily targets central nervous system pathways, making it a compound of significant interest in neuropharmacology and peptide-related research.
Each batch is tested using analytical methods such as HPLC and MS to confirm identity, purity, and quality. A complete Certificate of Analysis (COA) is available upon request.
Manufactured using advanced synthesis and purification processes, with purity ≥98%
Strict quality control ensures excellent batch-to-batch uniformity
Meets requirements for research-grade and API-level applications
Flexible specifications, packaging sizes, and quality grades upon request
